Andrew Witty

Latest stories

10h
FOX News
Glaxo bets it can shake up HIV treatmentHIV pill is powerful enough to suppress the virus with the help of just one oth
Glaxo bets it can shake up HIV treatment
FOX News / Posted 10 hours ago
HIV pill is powerful enough to suppress the virus with the help of just one other drug. That, according to Chief Executive Andrew Witty, would be a “game-changer,” because taking fewer drugs would produce fewer side effects. Now, Glaxo’s... Read more
7d
New Kerala
Sun Pharma's Dilip Sanghvi acquires Rs 6 9crores worth positive media visibility - newkerala.com #108264the brand message to the consumer and the media. Among International pharma br
Sun Pharma's Dilip Sanghvi acquires Rs 6 9crores worth positive media visibility - newkerala.com #108264
New Kerala / Posted 7 days ago
the brand message to the consumer and the media. Among International pharma brands, the most visible spokesperson was Andrew Witty, CEOGSK with2% of media articles with positive value worth Rs 5 crores followed by Edgard A Olaizola, Managing... Read more
11d
Fortune
How Fortune’s ‘Change the World’ Companies Profit From Doing Goodto serve not just patients in the wealthier nations of the West but also consum
How Fortune’s ‘Change the World’ Companies Profit From Doing Good
Fortune / Posted 11 days ago
to serve not just patients in the wealthier nations of the West but also consumers in less developed countries—or what CEO Andrew Witty calls “the other 6 billion” people in the world. The company spent some three decades developing a vaccine for... Read more
17d
Japan Today
Future of drug pricing: Paying for benefits not per pill ‹ Japan Todaydrug back in 2007 and Italy also uses patient data to pay for cancer drugs base
Future of drug pricing: Paying for benefits not per pill ‹ Japan Today
Japan Today / Posted 17 days ago
drug back in 2007 and Italy also uses patient data to pay for cancer drugs based on actual patient responses. GSK CEO Andrew Witty sees this outcomes-based approach slowly becoming the norm in more disease areas and geographies. “Whoever wins... Read more
20d
Newsmax
Should Drug Prices Be Tied to Benefits?drug back in 2007 and Italy also uses patient data to pay for cancer drugs base
Should Drug Prices Be Tied to Benefits?
Newsmax / Posted 20 days ago
drug back in 2007 and Italy also uses patient data to pay for cancer drugs based on actual patient responses. GSK CEO Andrew Witty sees this outcomes-based approach slowly becoming the norm in more disease areas and geographies. "Whoever wins... Read more
3 related stories
20d
Fortune
Here's How Your Drugs May Get Priced in the Futuredrug back in 2007 and Italy also uses patient data to pay for cancer drugs base
Here's How Your Drugs May Get Priced in the Future
Fortune / Posted 20 days ago
drug back in 2007 and Italy also uses patient data to pay for cancer drugs based on actual patient responses. GSK CEO Andrew Witty sees this outcomes-based approach slowly becoming the norm in more disease areas and geographies. “Whoever wins... Read more
3 related stories
20d
Reuters
Future of drug pricing: paying for benefits not per pilldrug back in 2007 and Italy also uses patient data to pay for cancer drugs base
Future of drug pricing: paying for benefits not per pill
Reuters / Posted 20 days ago
drug back in 2007 and Italy also uses patient data to pay for cancer drugs based on actual patient responses. GSK CEO Andrew Witty sees this outcomes-based approach slowly becoming the norm in more disease areas and geographies. "Whoever wins... Read more
3 related stories
20d
Times of Malta
Paying for medicines per pill could soon be a thing of the pastdrug back in 2007 and Italy also uses patient data to pay for cancer drugs base
Paying for medicines per pill could soon be a thing of the past
Times of Malta / Posted 20 days ago
drug back in 2007 and Italy also uses patient data to pay for cancer drugs based on actual patient responses. GSK CEO Andrew Witty sees this outcomes-based approach slowly becoming the norm in more disease areas and geographies. "Whoever wins... Read more
3 related stories
21d
Daily Mirror
UK's biggest bosses bag 10% pay rise while workers get less than living wageby Berkley Group boss Tony Pidgeley who bagged £23.3m, up from £19.5m in 2014.
UK's biggest bosses bag 10% pay rise while workers get less than living wage
Daily Mirror / Posted 21 days ago
by Berkley Group boss Tony Pidgeley who bagged £23.3m, up from £19.5m in 2014. GlaxoSmithKline chief executive Sir Andrew Witty got a particularly big rise. His total package went from £3.9m in 2014 to almost £6.7m last year. High pay also... Read more
7 related stories
23d
The Comet
Does Brexit spell boom or bust for North Herts businesses? The Comet assesses the post referendum economic climatein Herts. Stevenage is not mentioned in those plans, but can surely only benefi
Does Brexit spell boom or bust for North Herts businesses? The Comet assesses the post referendum economic climate
The Comet / Posted 23 days ago
in Herts. Stevenage is not mentioned in those plans, but can surely only benefit from the commitment. GSK chief executive Andrew Witty said: “It is testament to our skilled UK workforce and the country’s leading position in life sciences that we... Read more
24d
Investors Chronicle
GSK and Google join forces in bioelectronics projectprice soar as investors looked to park their cash in a perceived safe-haven, hi
GSK and Google join forces in bioelectronics project
Investors Chronicle / Posted 24 days ago
price soar as investors looked to park their cash in a perceived safe-haven, high-income stock. Last week, chief executive Andrew Witty announced that the group would spend £275m on revamping its UK science sites; a relief for those concerned that... Read more
54 related stories
28d
Market Watch
Glaxo, Alphabet plan $700 mln bioelectric venturecompany said it would spend GBP275 million to increase capacity at three of its
Glaxo, Alphabet plan $700 mln bioelectric venture
Market Watch / Posted 28 days ago
company said it would spend GBP275 million to increase capacity at three of its U.K. factories, a decision Chief Executive Andrew Witty said was made despite Britain's Brexit vote. -- Tapan Panchal contributed to this article. Write to Denise... Read more
28d
express
It’s the EU facing economic disaster NOT Brexit Britain, argues LEO MCKINSTRYweek pharmaceutical conglomerate GlaxoSmithKline revealed plans to invest £275m
It’s the EU facing economic disaster NOT Brexit Britain, argues LEO MCKINSTRY
express / Posted 28 days ago
week pharmaceutical conglomerate GlaxoSmithKline revealed plans to invest £275million at three of its British plants. Sir Andrew Witty, the company’s CEO, had said before the referendum that a vote to leave the EU would be “a mistake” because it... Read more
29d
SKY News
PM Holds Talks With 'FTSE Fraud Squad'result. Among the other attendees, whose spouses were also invited, were Jes S
PM Holds Talks With 'FTSE Fraud Squad'
SKY News / Posted 29 days ago
result. Among the other attendees, whose spouses were also invited, were Jes Staley, the Barclays chief executive; Sir Andrew Witty of GSK; Warren East, boss of Rolls Royce; and the Tesco chief executive Dave Lewis. Barclays is being probed by... Read more
m
Tax-News.com
GlaxoSmithKline Confident In UK HQ Despite Brexita lower rate of corporation tax on profits generated from UK-owned intellectual
GlaxoSmithKline Confident In UK HQ Despite Brexit
Tax-News.com / Posted 1 months ago
a lower rate of corporation tax on profits generated from UK-owned intellectual property." GSK's Chief Executive Sir Andrew Witty had supported the campaign for the UK to remain in the European Union (EU). He told the BBC, "We believed a vote... Read more
5 related stories

People in this news